Altamira Therapeutics Ltd.: xbrl:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives

Value	`{"amount": -224086, "currency": "USD"}`
Period	2023-01-01 – 2023-06-30
Status	current
Entity	Altamira Therapeutics Ltd.

Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-24-081199
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/6c444123-92d9-4cb8-af80-9986dee00dd1

History

supersedes {"unit": "CHF", "value": -204344} (evidence 0001213900-23-075871)